Nutritional Status of Adult Slovenes After the Covid-19 Epidemic

NCT05438966 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 833

Last updated 2022-09-02

No results posted yet for this study

Summary

There is objective need to examine nutritional status (i.e., body mass index (BMI), body composition and dietary intake) of healthy adult Slovenes after SARS-CoV-2 (Covid-19) epidemic period.

In the Slovenian (pair of European Union) adult population (with only 2 million inhabitants), we do not yet have representative data on the body composition of adult Slovenes published in the scientific literature.

In the study after the Covid-19 pandemic period (4th wave) the investigators will use medically approved body analyzer (Tanita 780 S MA, Tokyo, Japan) and standardized food frequency questionnaire (FFQ). In addition, the investigators will measured body height of the participants with a portable altimeter (ADE MZ10042, Germany).

The research will include randomly recruited adults (participants) who will attend various free or/and paid publicly available seminars, congresses and fairs in Slovenia, directly unrelated topics to physical activity or healthy eating (i.e., healthy and active lifestyle) thus obtaining a more realistic current population status.

Conditions

  • Body Weight
  • Nutrition, Healthy
  • COVID-19 Pandemic

Interventions

OTHER

No intervention

No intervention

Sponsors & Collaborators

  • Barbara Jakše s.p.

    lead OTHER

Principal Investigators

  • Boštjan Jakše, PhD · Independent Researcher

  • Stanislav Pinter, PhD · University of Ljubljana

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-06-28
Primary Completion
2022-08-31
Completion
2022-09-01

Countries

  • Slovenia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05438966 on ClinicalTrials.gov